Sensex
82,140.20 profit arw 354.46 (0.43%)
Nifty
25,165.05 profit arw 95.85 (0.38%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
Equity

As on : 09-Sep-2025
Hot Pursuit
09-Sep-2025     09:51

Morepen Lab jumps after subsidiary inks JV with UAE firm

The proposed joint venture company, to be incorporated in India, will focus on manufacturing, trading and selling medical devices. Both partners will contribute equally in the share capital of the new entity, with Morepen Laboratories holding an indirect 30% stake through its subsidiary.

The company clarified that the joint venture will be treated as a related party but its promoters have no direct interest apart from their shareholding in Morepen Medipath.

Morepen Laboratories is a vertically integrated pharmaceutical and healthcare company delivering APIs, branded generics, medical devices, and consumer wellness products worldwide.

On a consolidated basis, net profit of Morepen Laboratories declined 70.28% to Rs 10.75 crore while net sales declined 6.59% to Rs 425.24 crore in Q1 June 2025 over Q1 June 2024.

Powered by Capital Market - Live News

INDIAN INDICES

Sensex

82,140.20 354.46 (0.43%)

Nifty

25,165.05 95.85 (0.38%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

26,446.57 58.40(0.22%)